Bivalirudin is indicated for use as an anticoagulant with unstable angina undergoing percutaneous transluminal coronary angioplasty (PTCA). Bivalirudin is intended for use with aspirin.
Bivalirudin
Specifications
Human
Injectable
Commercial
FEATURED Products
Related Media
New Product Development
Where our FDA approved laboratory begins developing products, formulating and validating methods to ensure quality.
Compliance Audits
Where we audit and champion our partner factories to exceed cGMP standards set by authorities.
Regulatory Services
Where all submissions are filed with the knowledge and experience of our 550+ worldwide approvals on record.